Related Experiment Video
Updated: Mar 11, 2026

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Sickle cell vaso-occlusive crisis: it's a gut feeling
Seah H Lim1, Loren Fast2, Alison Morris3
1Division of Hematology and Oncology, Rhode Island Hospital/Brown University Warren Alpert Medical School, Room 140 APC Building, 593 Eddy Street, Providence, RI, USA. seahhlim@yahoo.com.
Altered gut microbiota in sickle cell disease (SCD) patients may drive vaso-occlusive crises by increasing aged neutrophils. Modulating the gut microbiome could be a novel therapeutic strategy for SCD.
Area of Science:
- Hematology
- Microbiology
- Immunology
Background:
- Activated neutrophils play a critical role in the pathogenesis of vaso-occlusive crisis (VOC) in sickle cell disease (SCD).
- Recent research highlights the intestinal microbiota's influence on regulating neutrophil populations.
- Aged neutrophils, a subset of overly activated neutrophils, are implicated in severe disease complications.
Purpose of the Study:
- To explore the link between abnormal intestinal microbiota and the development of VOC in SCD.
- To discuss the potential of targeting the gut microbiome as a therapeutic strategy for SCD.
Main Methods:
- Review of current laboratory and clinical evidence on SCD pathogenesis.
- Analysis of a recent study in murine models of SCD involving intestinal microbiota manipulation.
- Discussion of potential mechanisms connecting gut dysbiosis to neutrophil activation in SCD.
Main Results:
- A study in murine SCD models showed that reducing aged neutrophils protected against fatal TNFα-induced VOC.
- The intestinal microbiota was identified as a regulator of aged neutrophil numbers in these models.
- Abnormalities in the intestinal microbiota are proposed to contribute to increased aged neutrophils in SCD.
Conclusions:
- Patients with SCD may exhibit an abnormal intestinal microbiota, contributing to VOC development.
- Targeting the intestinal microbiota represents a promising avenue for future SCD therapies.
- Restoring microbial balance in the gut may alleviate VOC and improve patient outcomes.
More Related Videos
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Vascular Spasm
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Acute Coronary Syndrome V: Nursing Management
Cystic Fibrosis: Management
Sinus disease and chronic...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies